Home » U.S. Authorities Quiz Astrazeneca Over Brilinta Clinical Trial
U.S. Authorities Quiz Astrazeneca Over Brilinta Clinical Trial
The U.S. Department of Justice has opened an investigation into a clinical trial testing AstraZeneca’s Brilinta. While the cause of the investigation is being kept quiet, the drugmaker says it is cooperating with authorities.
Reuters
Reuters
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May